Skip to main navigation Skip to search Skip to main content

I-124 PET Directed Redifferentiation Therapy for Radioiodine Refractory Thyroid Cancer: the I-FIRST Study

    Project Details

    StatusFinished
    Effective start/end date1/06/21 → 31/05/26

    Funding

    • 2021/GR001659